Olaparib sensitivity characteristic of Brca1‐deleted mouse mammary tumour‐derived cells is abrogated upon loss of 53BP1 (Fig 2B; Bouwman et al, 2010; Tacconi et al, 2017). This evidence concerns the gene TP53BP1 and breast cancer.